|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/43 | |
| A61K 38/48 | |||
| A61K 9/00 | |||
| A61P 25/00 |
| (11) | Number of the document | 2583687 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13151292.3 |
| Date of filing the European patent application | 2008-02-14 | |
| (97) | Date of publication of the European application | 2013-04-24 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 890052 P | 2007-02-15 | US |
| (72) |
Blumenfeld, Andrew M., US
Gaylis, Franklin David, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
Gaylis, Franklin David, 6738 Del Cerro Boulevard, San Diego CA 92120, US |
| (54) | USE OF BOTULINUM TOXIN FOR TREATING HYPERHYDROSIS |
| USE OF BOTULINUM TOXIN FOR TREATING HYPERHYDROSIS |